Intramuscular testosterone undecanoate for the treatment of male hypogonadism–review of recent data
Authors:
- Markus SchubertMSMarkus Schubert
- Michael ZitzmannMZMichael Zitzmann
- Aksam YassinAYAksam Yassin
- 1 December 2006
- journal article
- review article
- Published by SAGE Publications in The Journal of Men's Health & Gender
- Vol. 3 (4) , 356-362
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Investigation, Treatment and Monitoring of Late-Onset Hypogonadism in MalesEuropean Urology, 2005
- Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with HypogonadismThe Journal of Clinical Endocrinology & Metabolism, 2004
- The aging male: testosterone deficiency and testosterone replacement. An up-dateAtherosclerosis, 2004
- Testosterone and atherosclerosisGrowth Hormone & IGF Research, 2003
- Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal menClinical Endocrinology, 1999
- I. IntroductionThe Journal of Clinical Endocrinology & Metabolism, 1998
- Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal menThe Journal of Clinical Endocrinology & Metabolism, 1992
- Biological Actions of AndrogensEndocrine Reviews, 1987
- Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal menInternational Journal of Andrology, 1984
- Bioavailability and LH-Suppressing Effect of Different Testosterone Preparations in Normal and Hypogonadal MenHormone Research, 1976